Company intelligence / Profile preview

Jinsheng Da Ren Tang

Tianjin, Tianjin, China

Ownership: Private
Development stage: Other

Overview

Tianjin Pharmaceutical Da Ren Tang Group is a leading, commercial-stage Chinese pharmaceutical company specializing in traditional Chinese medicine. Its product portfolio covers 599 approved medicines in 13 categories with multiple major brands, including over 120 exclusive products and 75 included in the National Essential Medicine Catalogue. Several products are state-protected or considered 'treasure-class' Chinese medicines[1].

Therapeutic areas: EndocrinologyRheumatologyGastroenterologyPulmonologyDermatologyCardiovascularOtherOncologyWomen's Health
Modalities: Small moleculeBiologicTraditional Chinese medicineHerbal medicine
Industry: Pharma

Drug pipeline

4 assets

Qing Gong Shou Tao Pill

Unknown

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Jinsheng Da Ren Tang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jinsheng Da Ren Tang.

Explore the full profile